Specialized Compounds for High-Risk and Extreme Environments
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts compounds for treating coronavirus infections to meet the unique demands of high-security, disaster relief, extreme weather, remote, and limited medical infrastructure environments.
Background and Problem Solved
The original patent disclosed compounds for treating coronavirus infections, but it did not address the specific challenges of administering these compounds in high-risk or extreme environments. The new inventive concept solves this problem by introducing specialized variations and niche solutions tailored to these environments.
Detailed Description of the Inventive Concept
The inventive concept encompasses four distinct variations of the original compounds: 1) a system for high-security environments featuring tamper-evident delivery mechanisms, 2) a method for disaster relief operations with rapid deployment and administration capabilities, 3) a composition for extreme weather conditions packaged in weather-resistant containers, and 4) a kit for remote or isolated areas with portable administration devices and storage capabilities for extreme temperatures. These variations ensure the effective treatment of coronavirus infections in environments where standard administration methods are not feasible.
Novelty and Inventive Step
The new inventive concept introduces novel features that differentiate it from the original patent, including secure delivery mechanisms, rapid deployment and administration capabilities, weather-resistant packaging, and portable administration devices. These innovations address specific challenges in high-risk and extreme environments, providing a non-obvious solution to the problem of administering coronavirus treatments in these contexts.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include variations in the compound formulation, delivery mechanism, or packaging materials to further adapt to specific environmental challenges. Additionally, the inventive concept could be expanded to address other high-risk or extreme environments not currently addressed.
Potential Commercial Applications and Market
The specialized compounds for high-risk and extreme environments have significant commercial potential in industries such as biodefense, emergency response, and remote healthcare. The market demand for these solutions is driven by the need for effective coronavirus treatments in challenging environments, and the inventive concept is well-positioned to capitalize on this demand.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/122 |
| A | A61 | A61K9/0053 |
| A | A61 | A61K9/0095 |
| A | A61 | A61K9/127 |
| A | A61 | A61K9/2009 |
| A | A61 | A61K9/2013 |
| A | A61 | A61K9/2018 |
| A | A61 | A61K9/2054 |
| A | A61 | A61K9/2095 |
| A | A61 | A61K9/282 |
| A | A61 | A61K9/2833 |
| A | A61 | A61K9/4833 |
| A | A61 | A61K9/4858 |
| A | A61 | A61K9/4866 |
| A | A61 | A61K31/198 |
| A | A61 | A61K31/222 |
| A | A61 | A61K31/381 |
| A | A61 | A61K31/40 |
| A | A61 | A61K31/422 |
| A | A61 | A61K31/433 |
| A | A61 | A61K31/454 |
| A | A61 | A61K31/513 |
| A | A61 | A61K31/536 |
| A | A61 | A61K36/30 |
| A | A61 | A61P31/14 |
| A | A61 | A61K2236/51 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical Formulation and Drug Delivery Systems, with specialized expertise in coronavirus treatment compounds, drug packaging, and administration technologies for challenging environments
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical scientist or biomedical engineer with advanced degree, expertise in drug formulation, medical device design, and experience developing treatments for infectious diseases, particularly with knowledge of pharmaceutical packaging and delivery mechanisms
Obviousness Rationale
A person having ordinary skill would recognize that the source patent's coronavirus treatment compounds inherently require specialized delivery mechanisms for various environmental conditions. The PTD's variations represent predictable engineering solutions that address known challenges in drug administration, using standard design techniques familiar to pharmaceutical researchers working with sensitive medical compounds.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,517 |
|---|---|
| Title | Compounds for treating corona virus infection |
| Assignee(s) | NLC Pharma Ltd |